Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Jun 26, 2021 12:14am
114 Views
Post# 33455286

RE:$70M cash with priority voucher sale

RE:$70M cash with priority voucher sale

Please do your due diligence on this stock. Thomson is a corporate bully. 

stockbuphoon wrote:

Liminal gets $70M for selling voucher at $100M (70%). They have less than a years cash and they tanked their failed top 4050 indications saying they would not put them in phase 2 in late May PR. That's why all the analysts tanked their price targets. Liminal did nothing with $500M spent for past 4 years except getting a voucher for $70M. What will they do with $70M in a year with preclinical trials? Huge markets? Tell us which? You have no clue or you would lay out the valuation potential. Nada, nothing. 

So, either everything in this company was lies or Thomson is hiding potential of 4050 as Boehringher wanted to pay $900M instead of $1B in summer of 2018. Did you learn something here tonight? This is fun! 



<< Previous
Bullboard Posts
Next >>